Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1983 Nov;38(11):813–821. doi: 10.1136/thx.38.11.813

Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.

A J Williams, M S Baghat, D E Stableforth, R M Cayton, P M Shenoi, C Skinner
PMCID: PMC459669  PMID: 6648863

Abstract

Nine of 14 asthmatic patients who presented with persistent dysphonia while taking inhaled corticosteroids had a bilateral adductor vocal cord deformity with bowing of the cords on phonation. This causes the dysphonia and usually occurs without candidiasis. It was seen with beclomethasone dipropionate (in both pressurised aerosol and dry powder preparations), betamethasone valerate, and budesonide. It was related to the dose and potency of inhaled steroid and may represent a local steroid myopathy. It was reversed when the inhaled steroid was stopped, although resolution sometimes took weeks. Laryngeal candidiasis may have contributed to the vocal cord abnormality in two of these nine patients. Of the five patients without vocal cord deformity, laryngeal candidiasis was the sole cause of dysphonia in three. In the remaining two dysphonia was thought to be psychogenic. The vocal cord deformity may exist subclinically. Of nine patients who started to take aerosol steroid and who were examined monthly for one year, three developed vocal cord deformity but only one had persistent dysphonia. Vocal abuse did not appear to contribute to dysphonia.

Full text

PDF
813

Images in this article

814Image
on p.814
817Image
on p.817

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clark T. J. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet. 1972 Jun 24;1(7765):1361–1364. doi: 10.1016/s0140-6736(72)91094-x. [DOI] [PubMed] [Google Scholar]
  2. Cooper E. J., Grant I. W. Beclomethasone dipropionate aerosol in treatment of chronic asthma. Q J Med. 1977 Jul;46(183):295–308. [PubMed] [Google Scholar]
  3. Davies D. S. Pharmacokinetics of inhaled substances. Postgrad Med J. 1975;51(7 Suppl):69–75. [PubMed] [Google Scholar]
  4. Dolovich M. B., Killian D., Wolff R. K., Obminski G., Newhouse M. T. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis. 1977 Mar;115(3):397–402. doi: 10.1164/arrd.1977.115.3.397. [DOI] [PubMed] [Google Scholar]
  5. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Preliminary report of the Brompton Hospital-Medical Research Council Collaborative Trial. Lancet. 1974 Aug 10;2(7876):303–307. [PubMed] [Google Scholar]
  6. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthma. Second report of the Brompton Hospital/Medical Research Council Collaborative Trial. Br J Dis Chest. 1979 Apr;73(2):121–132. [PubMed] [Google Scholar]
  7. Earis J. E., Bernstein A. Misuse of pressurised nebulisers. Br Med J. 1978 Jun 10;1(6126):1554–1554. doi: 10.1136/bmj.1.6126.1554-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gaddie J., Petrie G. R., Reid I. W., Skinner C., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973 Aug 11;2(7824):280–281. doi: 10.1016/s0140-6736(73)90788-5. [DOI] [PubMed] [Google Scholar]
  9. Gaddie J., Reid I. W., Skinner C., Petrie G. R., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate in chronic bronchial asthma. Lancet. 1973 Mar 31;1(7805):691–693. doi: 10.1016/s0140-6736(73)91479-7. [DOI] [PubMed] [Google Scholar]
  10. Johansson S. A., Andersson K. E., Brattsand R., Gruvstad E., Hedner P. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol. 1982;22(6):523–529. doi: 10.1007/BF00609625. [DOI] [PubMed] [Google Scholar]
  11. Kass I., Vijayachandra Nair S., Patil K. D. Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthmatic patients. An assessment of 18 months of therapy. Chest. 1977 Jun;71(6):703–707. doi: 10.1378/chest.71.6.703. [DOI] [PubMed] [Google Scholar]
  12. Kerigan A. T., Pugsley S. O., Cockcroft D. W., Hargreave F. E. Subsittution of inhaled beclomethasone dipropionate for ingested prednisone in steroid-dependent asthmatics. Can Med Assoc J. 1977 Apr 23;116(8):867–871. [PMC free article] [PubMed] [Google Scholar]
  13. Kriz R. J., Chmelik F., doPico G., Reed C. E. A one-year trial of triamcinolone acetonide aerosol in severe steroid-dependent asthma. Chest. 1977 Jul;72(1):36–44. doi: 10.1378/chest.72.1.36. [DOI] [PubMed] [Google Scholar]
  14. McAllen M. K., Kochanowski S. J., Shaw K. M. Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment. Br Med J. 1974 Feb 2;1(5900):171–175. doi: 10.1136/bmj.1.5900.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milne L. J., Crompton G. K. Beclomethasone dipropionate and oropharyngeal candidiasis. Br Med J. 1974 Sep 28;3(5934):797–798. doi: 10.1136/bmj.3.5934.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Newhouse M. T., Ruffin R. E. Deposition and fate of aerosolized drugs. Chest. 1978 Jun;73(6 Suppl):936–943. doi: 10.1378/chest.73.6.936. [DOI] [PubMed] [Google Scholar]
  17. Newman S. P., Pavia D., Morén F., Sheahan N. F., Clarke S. W. Deposition of pressurised aerosols in the human respiratory tract. Thorax. 1981 Jan;36(1):52–55. doi: 10.1136/thx.36.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pingleton W. W., Bone R. C., Kerby G. R., Ruth W. E. Oropharyngeal candidiasis in patients treated with triamcinolone acetonide aerosol. J Allergy Clin Immunol. 1977 Oct;60(4):254–258. doi: 10.1016/0091-6749(77)90140-3. [DOI] [PubMed] [Google Scholar]
  19. Smits B. J., Prior A. P., Arblaster P. G. Incidence of candida in hospital in-patients and the effects of antibiotic therapy. Br Med J. 1966 Jan 22;1(5481):208–210. doi: 10.1136/bmj.1.5481.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Toogood J. H., Jennings B., Greenway R. W., Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol. 1980 Feb;65(2):145–153. doi: 10.1016/0091-6749(80)90200-6. [DOI] [PubMed] [Google Scholar]
  21. Toogood J. H., Lefcoe N. M., Haines D. S., Jennings B., Errington N., Baksh L., Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 1977 Apr;59(4):298–308. doi: 10.1016/0091-6749(77)90051-3. [DOI] [PubMed] [Google Scholar]
  22. Vogt F. C. The incidence of oral candidiasis with use of inhaled corticosteroids. Ann Allergy. 1979 Oct;43(4):205–210. [PubMed] [Google Scholar]
  23. Willey R. F., Milne L. J., Crompton G. K., Grant I. W. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest. 1976 Jan;70(1):32–38. doi: 10.1016/0007-0971(76)90004-8. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES